Meropenem: Definition and Structure
Meropenem is a broad-spectrum antibiotic belonging to the carbapenem class. It is a synthetic derivative of thienamycin, a natural antibiotic produced by Streptomyces clavuligerus. Meropenem exerts its antibacterial activity by inhibiting the synthesis of bacterial cell walls.
Clinical Applications and Benefits
Meropenem is primarily used to treat serious bacterial infections, including:
Dosage and Administration
Meropenem is administered intravenously, typically every 8 hours. The dosage varies depending on the severity of the infection and the patient's renal function.
Pharmacokinetics
Meropenem has a high bioavailability after intravenous administration, reaching peak plasma concentrations within 1 hour. It is widely distributed throughout the body, including the lungs, kidneys, liver, and cerebrospinal fluid. The elimination half-life of meropenem is approximately 1 hour.
Spectrum of Activity
Meropenem has a broad spectrum of antibacterial activity, covering both Gram-positive and Gram-negative bacteria. It is particularly effective against aerobic and anaerobic bacteria, including:
Mechanism of Resistance
Resistance to meropenem can develop through various mechanisms, including:
Use During Pregnancy and Lactation
Meropenem should be used during pregnancy only if the potential benefits outweigh the risks. It is excreted in human milk and should be used with caution in nursing mothers.
Safety and Adverse Effects
Meropenem is generally well-tolerated. The most common adverse effects include:
Important Considerations for Use
A doctor prescribed meropenem to a patient with a severe infection. However, the patient returned to the clinic a few days later, complaining that the antibiotic made their hair turn blue. The doctor was baffled and consulted with a pharmacist, who discovered that the patient had accidentally taken methylene blue instead of meropenem. Lesson: Always double-check the medication labels to prevent unexpected side effects.
A hospital staff member mistakenly administered meropenem to a patient who was allergic to penicillin. The patient immediately developed a severe anaphylactic reaction, requiring emergency treatment with epinephrine and corticosteroids. Lesson: Allergy histories must be carefully reviewed before administering any medication.
A patient was admitted to the hospital with a life-threatening infection. Meropenem was the recommended antibiotic, but the patient's insurance denied coverage due to its high cost. The family was desperate for options and eventually sought help from a charity that provided financial assistance. Lesson: Cost should not be a barrier to accessing essential medical treatments.
Importance of Meropenem
Meropenem plays a critical role in treating serious bacterial infections. It is a valuable antibiotic due to its broad spectrum of activity, high efficacy, and generally favorable safety profile.
Benefits of Meropenem
Meropenem is used to treat serious bacterial infections, such as pneumonia, urinary tract infections, and intra-abdominal infections.
Meropenem is administered intravenously, typically every 8 hours.
The dosage of meropenem varies depending on the severity of the infection and the patient's renal function.
Diarrhea is a common adverse effect of meropenem, affecting up to 10% of patients.
Yes, meropenem has a low potential for cross-reactivity with penicillin, making it suitable for patients with penicillin allergies.
Meropenem is effective against a wide range of antibiotic-resistant bacteria, including multidrug-resistant strains.
Potential risks of meropenem include carbapenem resistance, nephrotoxicity, and hypersensitivity reactions.
Meropenem should not be used in patients with a known history of hypersensitivity to the drug or in patients with severe renal impairment.
Meropenem is a valuable antibiotic that plays a significant role in treating serious bacterial infections. By understanding its benefits, risks, and appropriate use, healthcare professionals can optimize patient outcomes and contribute to the responsible stewardship of antibiotics.
Additional Resources:
Trial | Infection Type | Efficacy | Safety |
---|---|---|---|
1 | Pneumonia | 85% | Good |
2 | Urinary tract infections | 92% | Good |
3 | Intra-abdominal infections | 88% | Good |
Adverse Effect | Frequency | Severity |
---|---|---|
Nausea | 10-20% | Mild |
Vomiting | 5-10% | Mild |
Diarrhea | 3-5% | Mild-moderate |
Rash | 1-2% | Mild-moderate |
Eosinophilia | Mild |
Patient Group | Dosage | Frequency |
---|---|---|
Adults with normal renal function | 500-1000 mg every 8 hours | Intravenous |
Adults with impaired renal function | 250-500 mg every 8-12 hours | Intravenous |
Children | 10-20 mg/kg every 8 hours | Intravenous |
2024-08-01 02:38:21 UTC
2024-08-08 02:55:35 UTC
2024-08-07 02:55:36 UTC
2024-08-25 14:01:07 UTC
2024-08-25 14:01:51 UTC
2024-08-15 08:10:25 UTC
2024-08-12 08:10:05 UTC
2024-08-13 08:10:18 UTC
2024-08-01 02:37:48 UTC
2024-08-05 03:39:51 UTC
2024-09-04 23:46:39 UTC
2024-09-04 23:47:01 UTC
2024-09-05 01:26:51 UTC
2024-09-05 01:39:24 UTC
2024-09-05 01:39:39 UTC
2024-09-06 00:02:49 UTC
2024-09-06 10:36:11 UTC
2024-09-06 10:36:21 UTC
2024-10-19 01:33:05 UTC
2024-10-19 01:33:04 UTC
2024-10-19 01:33:04 UTC
2024-10-19 01:33:01 UTC
2024-10-19 01:33:00 UTC
2024-10-19 01:32:58 UTC
2024-10-19 01:32:58 UTC